245 related articles for article (PubMed ID: 9831326)
41. Leukotriene B4 receptors on guinea pig alveolar eosinophils.
Maghni K; de Brum-Fernandes AJ; Földes-Filep E; Gaudry M; Borgeat P; Sirois P
J Pharmacol Exp Ther; 1991 Sep; 258(3):784-9. PubMed ID: 1653838
[TBL] [Abstract][Full Text] [Related]
42. Effect of cetirizine on human eosinophil superoxide generation, eosinophil chemotaxis and eosinophil peroxidase in vitro.
Okada C; Eda R; Miyagawa H; Sugiyama H; Hopp RJ; Bewtra AK; Townley RG
Int Arch Allergy Immunol; 1994; 103(4):384-90. PubMed ID: 8130652
[TBL] [Abstract][Full Text] [Related]
43. Biological activity of leukotriene B4 analogs: inhibition of guinea pig eosinophil migration in vitro by the 2,6-disubstituted pyridine analogs U-75,302 and U-75,485.
Taylor BM; Crittenden NJ; Bruden MN; Wishka DG; Morris J; Richards IM; Sun FF
Prostaglandins; 1991 Sep; 42(3):211-24. PubMed ID: 1664113
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of human eosinophil activation by a cysteinyl leukotriene receptor antagonist (pranlukast; ONO-1078).
Suzuki M; Kato M; Kimura H; Fujiu T; Morikawa A
J Asthma; 2003 Jun; 40(4):395-404. PubMed ID: 12870835
[TBL] [Abstract][Full Text] [Related]
45. Contribution of leukotriene B4 to airway inflammation and the effect of antagonists.
Richards IM; Sun FF; Taylor BM; Shields SK; Griffin RL; Morris J; Wishka DG; Smith HW; Johnson RA; Dunn CJ
Ann N Y Acad Sci; 1991; 629():274-87. PubMed ID: 1659282
[TBL] [Abstract][Full Text] [Related]
46. Leukotriene C4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on eosinophil activation.
Tamura N; Agrawal DK; Townley RG
J Immunol; 1988 Dec; 141(12):4291-7. PubMed ID: 2848892
[TBL] [Abstract][Full Text] [Related]
47. The effect of salmeterol and nimesulide on chemotaxis and synthesis of PAF and LTC4 by human eosinophils.
Tool AT; Mul FP; Knol EF; Verhoeven AJ; Roos D
Eur Respir J Suppl; 1996 Aug; 22():141s-145s. PubMed ID: 8871060
[TBL] [Abstract][Full Text] [Related]
48. Effects of platelet activating factor on the chemotaxis of normodense eosinophils from normal subjects.
Tamura N; Agrawal DK; Suliaman FA; Townley RG
Biochem Biophys Res Commun; 1987 Feb; 142(3):638-44. PubMed ID: 3030295
[TBL] [Abstract][Full Text] [Related]
49. Regulatory effect of cytokines on eosinophil degranulation.
Fujisawa T; Abu-Ghazaleh R; Kita H; Sanderson CJ; Gleich GJ
J Immunol; 1990 Jan; 144(2):642-6. PubMed ID: 2104901
[TBL] [Abstract][Full Text] [Related]
50. Formation of LTB4 by fMLP-stimulated alveolar macrophages accounts for eosinophil migration in vitro.
Hidi R; Coëffier E; Vargaftig BB
J Leukoc Biol; 1992 May; 51(5):425-31. PubMed ID: 1318347
[TBL] [Abstract][Full Text] [Related]
51. Antiallergic and antiasthmatic effects of a novel enhydrazinone ester (CEE-1): inhibition of activation of both mast cells and eosinophils.
Ezeamuzie CI; El-Hashim AZ; Renno WM; Edafiogho IO
J Pharmacol Exp Ther; 2014 Aug; 350(2):444-54. PubMed ID: 24917545
[TBL] [Abstract][Full Text] [Related]
52. Inhibitory effect of cyclosporin A on eosinophil infiltration in the guinea-pig lung induced by antigen, platelet-activating factor and leukotriene B4.
Lagente V; Carré C; Kyriacopoulos F; Boichot E; Mencia-Huerta JM; Braquet P
Eur Respir J; 1994 May; 7(5):921-6. PubMed ID: 8050549
[TBL] [Abstract][Full Text] [Related]
53. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.
Wardlaw AJ; Moqbel R; Cromwell O; Kay AB
J Clin Invest; 1986 Dec; 78(6):1701-6. PubMed ID: 3023451
[TBL] [Abstract][Full Text] [Related]
54. Selective eosinophil leukocyte recruitment by transendothelial migration and not by leukocyte-endothelial cell adhesion.
Morland CM; Wilson SJ; Holgate ST; Roche WR
Am J Respir Cell Mol Biol; 1992 May; 6(5):557-66. PubMed ID: 1316135
[TBL] [Abstract][Full Text] [Related]
55. Adenosine A3 receptor stimulation inhibits migration of human eosinophils.
Knight D; Zheng X; Rocchini C; Jacobson M; Bai T; Walker B
J Leukoc Biol; 1997 Oct; 62(4):465-8. PubMed ID: 9335316
[TBL] [Abstract][Full Text] [Related]
56. LTB4, a potent chemotactic factor for purified guinea-pig eosinophils: interference of PAF-acether antagonists.
Coëffier E; Joseph D; Vargaftig BB
Int J Immunopharmacol; 1991; 13(2-3):273-80. PubMed ID: 1649143
[TBL] [Abstract][Full Text] [Related]
57. Theophylline attenuates the neutrophil-dependent augmentation of eosinophil trans-basement membrane migration.
Kikuchi I; Kikuchi S; Kobayashi T; Takaku Y; Hagiwara K; Kanazawa M; Nagata M
Int Arch Allergy Immunol; 2007; 143 Suppl 1():44-9. PubMed ID: 17541276
[TBL] [Abstract][Full Text] [Related]
58. Effect of in vivo desensitization to leukotriene B4 on eosinophil infiltration in response to C5a in guinea-pig skin.
Pettipher ER; Salter ED; Showell HJ
Br J Pharmacol; 1994 Sep; 113(1):117-20. PubMed ID: 7812600
[TBL] [Abstract][Full Text] [Related]
59. Superoxide production by human eosinophils can be inhibited in an agonist-selective manner.
Bach MK; Brashler JR; Petzold EN; Sanders ME
Agents Actions; 1992 Jan; 35(1-2):1-11. PubMed ID: 1324597
[TBL] [Abstract][Full Text] [Related]
60. The effect of WEB 2086 on PAF-induced eosinophil chemotaxis and LTC4 production from eosinophils.
Miyagawa H; Nabe M; Hopp RJ; Okada C; Bewtra AK; Townley G
Agents Actions; 1992 Sep; 37(1-2):39-43. PubMed ID: 1456179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
